The acquisition gives Eli Lilly access to an experimental drug for types of inflammatory bowel diseases
for $3.2-billion in cash, the companies said on Monday, giving the U.S. drugmaker access to an experimental drug for types of inflammatory bowel diseases.
Morphic’s lead drug MORF-057 is an oral treatment that is being evaluated in two phase 2 studies in ulcerative colitis patients and one phase 2 study in Crohn’s disease. Last year, the U.S. Food and Drug Administration approved Lilly’s Omvoh for treating adults with moderate-to-severe active ulcerative colitis.
Johnson Share Lilly Drug Cent Study Colitis Lilly U.S. Food And Drug Administration Pfizer
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lilly agrees to buy U.S. biotech Morphic in US$3.2 billion dealEli Lilly & Co. agreed to buy U.S. biopharma company Morphic Holding Inc. for about US$3.2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses.
Read more »
Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal(Bloomberg) -- Eli Lilly & Co. agreed to buy U.S. biopharma company Morphic Holding Inc. for about $3.2 billion to gain experimental therapies for...
Read more »
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5...
Read more »
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatmentAn FDA panel voted unanimously to support Eli Lilly's Alzheimer's drug for use in adults 60-85 years old.
Read more »
FDA panel votes to recommend Eli Lilly's Alzheimer's drugA US Food and Drug Administration (FDA) panel voted unanimously 11-0 to recommend the approval of Eli Lilly's (LLY) Alzheimer's drug, donanemab. Yahoo...
Read more »
FDA approves Eli Lilly's Alzheimer's drug KisunlaEli Lilly's (LLY) Alzheimer's treatment drug Kisunla has gained approval by the US Food and Drug Administration. Yahoo Finance Health Reporter Anjalee...
Read more »